Tretinoin Capsule
FDA Label NDC 10370-268

36 label sections · Submitted to the FDA by Par Health Usa, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Par Health Usa, Llc for the product Tretinoin (NDC 10370-268). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: embryo-fetal toxicity and differentiation syndrome, 1 indications and usage, 2.1 important safety information, 2.2 recommended dosage, 3 dosage forms and strengths, 4 contraindications, 5.1 embryo-fetal toxicity, 5.2 differentiation syndrome, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.